Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong
· Delayed Price · Currency is HKD 6.30
+0.13 (2.11%)
Mar 10, 2026, 9:55 AM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 110.30 billion as of March 9, 2026. Its market cap has increased by 87.79% in one year.
Market Cap
110.30B
Enterprise Value
115.27B
Revenue
33.49B
Ranking
n/a
PE Ratio
26.15
Stock Price
6.30
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 110.30B, an increase of 33,326.76%. That is a compound annual growth rate of 25.65%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 98.84B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.06B |
| Innovent Biologics | 144.54B |
| WuXi Biologics | 150.36B |
| RemeGen | 59.85B |
| 3SBio | 53.95B |
| BeOne Medicines AG | 261.29B |
| Shanghai Henlius Biotech | 37.50B |